Cc1n[nH]c(C)c1Sc1ccccc1/N=C/c1cc(Cl)cc([N+](=O)[O-])c1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?